Aa Aa Aa
  • Investor Information Overview

Webcast ImageWebcast
Q3 2014 Sucampo Pharmaceuticals, Inc. Earnings Conference Call (Live)
11/06/14 at 8:30 a.m. ET
Corporate Profile
Sucampo Pharmaceuticals, Inc. is a publicly traded (NASDAQ: SCMP) global biopharmaceutical company focused on innovative research, discovery, development and commercialization of proprietary drugs to treat gastrointestinal, ophthalmic, neurologic, and oncology-based inflammatory disorders, and are also considering o  More >>
Stock Quote
SCMP (Common Stock)
ExchangeNASDAQ GM (US Dollar)
Change (%) Stock is Down 0.11 (1.31%)
Data as of 10/24/14 4:00 p.m. ET
Refresh quote
Recent NewsRSS   | More >>
10/24/14Sucampo Pharmaceuticals, Inc. Announces Third Quarter 2014 Earnings CallPrinter Friendly Version
10/23/14Sucampo Solidifies Leadership Team With Additions of CSO and Heads of Business Development, Regulatory AffairsPrinter Friendly Version
10/21/14Takeda and Sucampo Enter Into Global Licensing Agreement for AMITIZA(R) (lubiprostone)Printer Friendly Version
10/14/14Sucampo Announces Extension of AMITIZA(R) (lubiprostone) License and Collaboration Agreement With TakedaPrinter Friendly Version
Upcoming Events
11/06/14 8:30 a.m. ET
Q3 2014 Sucampo Pharmaceuticals, Inc. Earnings Conference Call
Quotes delayed at least 15 minutes. Market data provided by Interactive Data.

Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.